Imaging agents offer new view of inflammation, cancer

A series of novel imaging agents could make it possible to "see" tumors in their earliest stages, before they turn deadly. The compounds, derived from inhibitors of the enzyme cyclooxygenase-2 and detectable by positron emission tomography imaging, may have broad applications for cancer detection, diagnosis and treatment.

Read the whole article on Science Daily

More from Science Daily